ReviewCancers2022
Advances in the Preoperative Identification of Uterine Sarcoma.
Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Diagnostic Performance of Galectin-1 and Mucin-1 in Uterine Tumors: A Case-Control Study.Current issues in molecular biology · 2026Article
- Exploratory Preoperative Risk Stratification of Uterine Mesenchymal Tumors in Postmenopausal Women with Complementary Transcriptomic Analysis.Diagnostics (Basel, Switzerland) · 2026Article
- Review
- Article
- Incidental Gynecological Premalignant and Malignant Lesions in Patients Undergoing Hysterectomy for Benign Indications.Pakistan journal of medical sciences · 2026Article
- Article
- FibroidX: Vision Transformer-Powered Prognosis and Recurrence Prediction for Uterine Fibroids Using Ultrasound Images.Cancers · 2026Article
- Challenges in Differentiating Uterine Mesenchymal Tumors-Key Diagnostic Criteria.Journal of clinical medicine · 2025Review
- The value of multiparametric MRI-based habitat imaging for differentiating uterine sarcomas from atypical leiomyomas: a multicentre study.Abdominal radiology (New York) · 2025Article
- Clinico-radio-histopathological Correlation of Leiomyoma Variant, STUMP, and Sarcoma: A Retrospective Study.Oman medical journal · 2025Article
- Preoperative identification from occult leiomyosarcomas in laparoscopic hysterectomy and laparoscopic myomectomy: accuracy of the ultrasound scoring system (PRESS-US).La Radiologia medica · 2024Article
- Deep learning based uterine fibroid detection in ultrasound images.BMC medical imaging · 2024Article
- The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma.Journal of gynecologic oncology · 2024Article
- Contained Power Morcellation in Laparoscopic Uterine Myoma Surgeries: A Brief Review.Healthcare (Basel, Switzerland) · 2023Review
- Rapidly growing uterine myoma - should we be afraid of it?Przeglad menopauzalny = Menopause review · 2023Review
- The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy.International journal of molecular sciences · 2023Review
- Automated Uterine Fibroids Detection in Ultrasound Images Using Deep Convolutional Neural Networks.Healthcare (Basel, Switzerland) · 2023Article
- Article
- Review
- Overlap of Suspicious and Non-Suspicious Features in the Ultrasound Evaluations of Leiomyosarcoma: A Single-Center Experience.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Uterine sarcomas are rare malignant tumors of the uterus with a high degree of malignancy. Their clinical manifestations, imaging examination findings, and laboratory test results overlap with those of uterine fibroids. No reliable diagnostic criteria can distinguish uterine sarcomas from other uterine tumors, and the final diagnosis is usually only made after surgery based on histopathological evaluation. Conservative or minimally invasive treatment of patients with uterine sarcomas misdiagnosed preoperatively as uterine fibroids will shorten patient survival. Herein, we will summarize recent advances in the preoperative diagnosis of uterine sarcomas, including epidemiology and clinical manifestations, laboratory tests, imaging examinations, radiomics and machine learning-related methods, preoperative biopsy, integrated model and other relevant emerging technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.